All News from Accelerate Diagnostics

All News

Worldwide Antibiotic Awareness Week

Nov 18, 2016 — This week members from the healthcare community worldwide aim to increase awareness about #AntimicrobialResistance led by the World Health Organization and the Centers for Disease Control and Prevention. Accelerate Diagnostics stands with them to share the importance of reducing the misuse and overuse of antibiotics which has become a worldwide public health concern. Learn more […]

Continue reading ›

Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th

Oct 21, 2016 — TUCSON, Ariz., Oct. 21, 2016 (GLOBE NEWSWIRE) — Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to review the results at 4:15 p.m. ET. The quarterly financial […]

Continue reading ›

Accelerate Diagnostics Launches Redesigned Web Experience

Sep 27, 2016 — Accelerate Diagnostics, Inc. launches a new online experience at acceleratediagnostics.com to share updates about its products, technologies, and unique culture. The newly designed website includes an overview of some of the technologies specific to the company as well as the latest information about its first diagnostic platform and test kit.

Continue reading ›

Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8

Jul 22, 2016 — Accelerate Diagnostics, Inc. announced today it will report second-quarter 2016 financial results on Monday, August 8th.

Continue reading ›

Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit

Jul 11, 2016 — Accelerate Diagnostics, Inc. ("Accelerate") announced today the submission of a De Novo request for Evaluation of Automatic Class III Designation to the U.S. Food and Drug Administration (FDA) for its Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for positive blood culture samples.

Continue reading ›

Accelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference

Jun 14, 2016 — Accelerate Diagnostics, Inc. ("Accelerate") announced today the completion of clinical data collection intended for submission to the FDA in conjunction with its de novo 510k request for premarket clearance of the Accelerate Pheno™ system and Accelerate Pheno™ BC kit for positive blood cultures.

Continue reading ›

Accelerate Diagnostics to Present at the 36th Annual Growth Stock Conference

Jun 07, 2016 — Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, the company's president and chief executive officer, is scheduled to present to investors at the 36th Annual Growth Stock Conference hosted by William Blair & Company, L.L.C. on June 15, 2016 at 8:00 a.m. Central Time at the Four Seasons Hotel in Chicago, Illinois.

Continue reading ›

Accelerate Diagnostics Schedules First-Quarter 2016 Results Announcement and Webcast

Apr 25, 2016 — Accelerate Diagnostics, Inc. announced today it will report first-quarter 2016 financial results after market close on Thursday, May 12, 2016.

Continue reading ›

Accelerate Diagnostics to Present Data at European Congress

Apr 10, 2016 — Accelerate Diagnostics, Inc. announced today it will present data related to the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for positive blood cultures while attending the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Amsterdam, Netherlands.

Continue reading ›

District Court Dismisses Lawsuit Against Accelerate Diagnostics

Jan 29, 2016 — Accelerate Diagnostics, Inc. (Nasdaq:AXDX) ("Accelerate Diagnostics") announced today that the United States District Court for the District of Arizona granted Accelerate Diagnostics' Motion to Dismiss the class action lawsuit filed against it in March of 2015.

Continue reading ›